MRC1 and cancer: Therefore, we analyzed the expression correlation of FANCD2 and four MMR genes and identified that the expression of FANCD2 and these four MMR genes had a significant positive correlation, indicating that higher expression of FANCD2 correlated with lower response rates of cancer immunotherapy LUAD (Figure 6F).